On Air Now

Listen

Listen Live Now » 101.1 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
57° Feels Like: 57°
Wind: N 9 mph Past 24 hrs - Precip: 0.15”
Current Radar for Zip

Tonight

Thunderstorms 54°

Tomorrow

AM Rain 59°

Mon Night

Clear 39°

Alerts

Acorda's multiple sclerosis drug faces generic threat

(Reuters) - Acorda Therapeutics Inc said Actavis Plc plans to market a generic version of Acorda's multiple sclerosis treatment, Ampyra.

Ampyra, which was approved in January 2010, had net sales of $72.5 million in the first quarter ended March 31.

Acorda said Actavis has submitted a marketing approval application with the U.S. Food and Drug Administration for a generic version of the drug.

Acorda said it intends to vigorously defend its intellectual property rights.

(Reporting By Penumudi Amrutha; Editing by Sriraj Kalluvila)

Comments